Aquestive Therapeutics Inc (AQST)

Healthcare Pharmaceuticals & Medical Research Pharmaceuticals

Track

Stock chart

Ticker: AQST Exchange: NMS

Subscribe to get access to the transaction volume chart and in-chart transaction details

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Earnings

Earnings

Value bought

Past 90 days

Value sold

Past 90 days

Net insiders buying

Past 90 days

Trades (buy and sell)

Past 90 days

Company data

Subscribe to get access to the company description and key fundamental data (market cap, shares outstanding, dividend yield, % of shares held by insiders and more)

Download results Settings

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other

Notification date	Transaction date	B/S Transaction type	Insider and/or position	Nb. shares Price Value	Number of shares	Price	Value
2024-11-27	2024-11-26	S Sale	Jung Cassie Chief Operating Officer Officer	44 -100.0% 4.87 USD 214	44 -100.0%	4.87	USD 214
2024-03-19	2024-03-15	PS Planned sale	Schobel Alexander Mark Chief Innovation/Tech Officer Officer	50,000 -4.8% 6.00 USD 300,000	50,000 -4.8%	6.00	USD 300,000
2024-03-12	2024-03-08	PS Planned sale	Schobel Alexander Mark Chief Innovation/Tech Officer Officer	25,000 -2.3% 5.19 USD 129,685	25,000 -2.3%	5.19	USD 129,685
2022-06-15	2022-06-14	B Purchase	Boyd Peter E. SVP-Bus. Process & Info. Tech. Officer	5,000 +9.2% 0.81 USD 4,050	5,000 +9.2%	0.81	USD 4,050
2022-06-10	2022-06-08	B Purchase	Boyd Peter E. SVP-Bus. Process & Info. Tech. Officer	2,293 +4.4% 0.96 USD 2,201	2,293 +4.4%	0.96	USD 2,201
2022-06-10	2022-06-08	B Purchase	BRAENDER LORI J General Counsel Officer	13,761 +55.0% 0.96 USD 13,211	13,761 +55.0%	0.96	USD 13,211
2022-06-10	2022-06-08	B Purchase	Schobel Alexander Mark Chief Innovation/Tech Officer Officer	45,871 +5.5% 0.96 USD 44,036	45,871 +5.5%	0.96	USD 44,036
2022-06-10	2022-06-08	B Purchase	Barber Daniel Chief Executive Officer Officer	91,743 +90.0% 0.96 USD 88,073	91,743 +90.0%	0.96	USD 88,073
2021-02-10	2021-02-10	PS Planned sale	Schobel Alexander Mark Chief Innovation/Tech Officer Officer	23,460 -2.7% 6.75 USD 158,355	23,460 -2.7%	6.75	USD 158,355
2021-02-10	2021-02-09	PS Planned sale	Schobel Alexander Mark Chief Innovation/Tech Officer Officer	11,540 -1.3% 6.75 USD 77,895	11,540 -1.3%	6.75	USD 77,895
2021-02-09	2021-02-08	PS Planned sale	Schobel Alexander Mark Chief Innovation/Tech Officer Officer	40,792 -4.5% 6.50 USD 265,148	40,792 -4.5%	6.50	USD 265,148
2020-08-19	2020-08-18	PS Planned sale	Maxwell John T. SVP-Chief Financial Officer Officer	3,000 -2.0% 8.00 USD 24,000	3,000 -2.0%	8.00	USD 24,000
2020-06-05	2020-06-04	PS Planned sale	Kendall Keith J CEO and President Executive Director	50,000 -7.3% 5.11 USD 255,310	50,000 -7.3%	5.11	USD 255,310
2020-05-11	2020-05-08	PS Planned sale	Schobel Alexander Mark Chief Innovation/Tech Officer Officer	40,000 -4.2% 5.00 USD 200,000	40,000 -4.2%	5.00	USD 200,000
2020-05-01	2020-04-29	PS Planned sale	Schobel Alexander Mark Chief Innovation/Tech Officer	40,000 -3.8% 4.50 USD 180,000	40,000 -3.8%	4.50	USD 180,000
2020-05-04	2020-04-27	PS Planned sale	Schobel Alexander Mark Chief Innovation/Tech Officer	40,000 -4.1% 4.00 USD 160,000	40,000 -4.1%	4.00	USD 160,000
2020-05-04	2020-04-14	PS Planned sale	Schobel Alexander Mark Chief Innovation/Tech Officer	40,000 -3.9% 3.70 USD 148,000	40,000 -3.9%	3.70	USD 148,000
2020-03-18	2020-03-16	B Purchase	Boyd Peter E. SVP-Bus. Process & Info. Tech.	2,000 +4.0% 1.50 USD 3,000	2,000 +4.0%	1.50	USD 3,000
2020-03-18	2020-03-16	B Purchase	BRAENDER LORI J SVP, General Counsel	14,000 +127.3% 1.54 USD 21,624	14,000 +127.3%	1.54	USD 21,624
2019-08-27	2019-08-27	B Purchase	Barber Daniel SVP-Chief Operating Officer	2,000 +2.0% 3.99 USD 7,980	2,000 +2.0%	3.99	USD 7,980
2019-08-22	2019-08-21	B Purchase	Scibetta James S	900 +2.9% 3.81 USD 3,429	900 +2.9%	3.81	USD 3,429
2019-08-22	2019-08-20	B Purchase	Scibetta James S	11,310 +58.2% 3.80 USD 43,001	11,310 +58.2%	3.80	USD 43,001
2019-08-22	2019-08-19	B Purchase	Scibetta James S	10,761 +124.2% 3.77 USD 40,547	10,761 +124.2%	3.77	USD 40,547
2019-08-20	2019-08-14	B Purchase	Kendall Keith J CEO and President	1,000 +0.2% 3.65 USD 3,650	1,000 +0.2%	3.65	USD 3,650
2019-08-20	2019-08-14	B Purchase	Kendall Keith J CEO and President	1,000 +0.2% 3.70 USD 3,697	1,000 +0.2%	3.70	USD 3,697
2019-08-20	2019-08-13	B Purchase	Kendall Keith J CEO and President	1,000 +0.2% 4.05 USD 4,045	1,000 +0.2%	4.05	USD 4,045
2019-08-13	2019-08-12	B Purchase	Boyd Peter E. SVP-Bus. Process & Info. Tech.	600 +1.2% 3.81 USD 2,286	600 +1.2%	3.81	USD 2,286
2019-08-20	2019-08-09	B Purchase	Kendall Keith J CEO and President	2,000 +0.3% 4.00 USD 7,990	2,000 +0.3%	4.00	USD 7,990
2019-08-20	2019-08-09	B Purchase	Kendall Keith J CEO and President	1,000 +0.2% 3.93 USD 3,925	1,000 +0.2%	3.93	USD 3,925
2019-08-20	2019-08-09	B Purchase	Kendall Keith J CEO and President	2,000 +0.3% 3.84 USD 7,680	2,000 +0.3%	3.84	USD 7,680
2019-08-13	2019-08-09	B Purchase	BRAENDER LORI J SVP, General Counsel	10,000 +1000.0% 4.07 USD 40,747	10,000 +1000.0%	4.07	USD 40,747
2019-08-13	2019-08-09	B Purchase	Wood Theresa SVP-HR and Org. Development	1,000 +1.3% 3.99 USD 3,990	1,000 +1.3%	3.99	USD 3,990
2018-12-11	2018-12-10	B Purchase	Schobel Alexander Mark Chief Innovation/Tech Officer	1,000 +0.1% 7.78 USD 7,780	1,000 +0.1%	7.78	USD 7,780
2018-12-10	2018-12-10	B Purchase	Barber Daniel SVP-Chief Strategy/Dev Officer	1,000 +1.0% 8.00 USD 8,000	1,000 +1.0%	8.00	USD 8,000
2018-12-10	2018-12-06	B Purchase	Schobel Alexander Mark Chief Innovation/Tech Officer	2,000 +0.2% 8.69 USD 17,380	2,000 +0.2%	8.69	USD 17,380
2018-12-07	2018-12-06	B Purchase	Maxwell John T. SVP-Chief Financial Officer	5,000 +3.4% 8.87 USD 44,350	5,000 +3.4%	8.87	USD 44,350
2018-11-29	2018-11-27	B Purchase	BRAENDER LORI J General Counsel	1,000 +inf% 10.57 USD 10,570	1,000 +inf%	10.57	USD 10,570
2018-11-28	2018-11-27	B Purchase	Kendall Keith J CEO and President	1,000 +0.2% 9.87 USD 9,870	1,000 +0.2%	9.87	USD 9,870
2018-11-26	2018-11-26	B Purchase	Wood Theresa SVP-HR and Org. Development	500 +0.6% 10.34 USD 5,170	500 +0.6%	10.34	USD 5,170
2018-11-26	2018-11-23	B Purchase	Kendall Keith J CEO and President	1,950 +0.3% 9.90 USD 19,305	1,950 +0.3%	9.90	USD 19,305
2018-12-03	2018-11-21	B Purchase	Marshall Ken W. Commercial Leader	1,445 +inf% 10.15 USD 14,667	1,445 +inf%	10.15	USD 14,667
2018-11-26	2018-11-21	B Purchase	Kendall Keith J CEO and President	6,000 +1.0% 10.17 USD 61,020	6,000 +1.0%	10.17	USD 61,020
2018-11-26	2018-11-21	B Purchase	Boyd Peter E. SVP-Operations/Value Delivery	200 +0.4% 9.98 USD 1,996	200 +0.4%	9.98	USD 1,996
2018-11-26	2018-11-21	B Purchase	Maxwell John T. SVP-Chief Financial Officer	10,000 +7.2% 9.80 USD 98,000	10,000 +7.2%	9.80	USD 98,000
2018-11-26	2018-11-21	B Purchase	Schobel Alexander Mark Chief Innovation/Tech Officer	1,000 +0.1% 10.25 USD 10,250	1,000 +0.1%	10.25	USD 10,250
2018-07-26	2018-07-24	B Purchase	BRATTON DOUGLAS K Non-Executive Director Large shareholder	165,000 +inf% 15.00 USD 2,475,000	165,000 +inf%	15.00	USD 2,475,000

Aquestive Therapeutics Inc (AQST)

Track

Stock chart

Earnings

Value bought

Value sold

Net insiders buying

Trades (buy and sell)

Transactions

Insider

Sort by